Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Konstantine Xoinis"'
Publikováno v:
Case Reports in Critical Care, Vol 2018 (2018)
Central pontine myelinolysis (CPM) is rarely reported in pediatric patients with diabetic ketoacidosis (DKA). We report this case of a 16-year-old female with new onset diabetes presenting with DKA, who received aggressive fluid resuscitation and sod
Externí odkaz:
https://doaj.org/article/af1c8ceef18d441c9caa8cbea5126379
Autor:
Malia Rasa MD, James Musgrave MD, Keith Abe MD, Len Tanaka MD, Konstantine Xoinis MD, Bruce Shiramizu MD, Gretchen Foskett MD, Rhiana Lau MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 5 (2017)
Hemolytic uremic syndrome (HUS) can be classified as typical and atypical, and the treatment recommendations currently differ between the 2 types. Eculizumab is recommended as first-line treatment for atypical HUS; however, its use in typical HUS has
Externí odkaz:
https://doaj.org/article/a07ccabda34c4df2a092ad3e128164f3
Autor:
Prashant J, Purohit, Laurie, Yamamoto, Len Y, Tanaka, Konstantine, Xoinis, John, Harrington, Rupert, Chang, Andrew, Feng
Publikováno v:
Hawaii J Health Soc Welf
Pediatric advanced life support (PALS) recertification every two years is inadequate to maintain proficiency. The authors hypothesized that a standardized, recurring curriculum may enhance retention of cardiopulmonary resuscitation (CPR) skills. Mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4326ebda9854d7e7cac151d20b5f1098
https://pubmed.ncbi.nlm.nih.gov/32490399
https://pubmed.ncbi.nlm.nih.gov/32490399
Publikováno v:
Case Reports in Critical Care, Vol 2018 (2018)
Case Reports in Critical Care
Case Reports in Critical Care
Central pontine myelinolysis (CPM) is rarely reported in pediatric patients with diabetic ketoacidosis (DKA). We report this case of a 16-year-old female with new onset diabetes presenting with DKA, who received aggressive fluid resuscitation and sod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406697d4a172635d51c7a8228cf0d597
https://doi.org/10.1155/2018/4273971
https://doi.org/10.1155/2018/4273971
Autor:
Nelly Gutierrez Martinez, Surabhi Khasgiwala, Len Tanaka, Aileen Tanaka, Konstantine Xoinis, John Harrington, Keith Abe, Rupert Chang, Prashant Purohit
Publikováno v:
Critical Care Medicine. 50:395-395
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b46eaf35dc82210d72ac06dc192b4e43
https://doi.org/10.1097/01.ccm.0000809528.33901.df
https://doi.org/10.1097/01.ccm.0000809528.33901.df
Autor:
Brian Wu, Konstantine Xoinis, Matthew Careskey, Edward Fong, Danielle Levy, John Harrington, Len Tanaka, Prashant Purohit
Publikováno v:
Critical Care Medicine. 49:494-494
INTRODUCTION: We present a case of a medically nonadherent 16 years-old female with a history of moderate persistent asthma and vaping of nicotine and marijuana products who presented in severe respiratory distress during the COVID-19 pandemic She ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30ec34f4b6e4a1422d29df66669930e2
https://doi.org/10.1097/01.ccm.0000729856.48260.2f
https://doi.org/10.1097/01.ccm.0000729856.48260.2f
Autor:
Malia, Rasa, James, Musgrave, Keith, Abe, Len, Tanaka, Konstantine, Xoinis, Bruce, Shiramizu, Gretchen, Foskett, Rhiana, Lau
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports
Hemolytic uremic syndrome (HUS) can be classified as typical and atypical, and the treatment recommendations currently differ between the 2 types. Eculizumab is recommended as first-line treatment for atypical HUS; however, its use in typical HUS has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67c184fab08e7765d33fe54cfffec487
https://pubmed.ncbi.nlm.nih.gov/29152520
https://pubmed.ncbi.nlm.nih.gov/29152520
Autor:
James Musgrave, Malia Rasa, Gretchen Foskett, Konstantine Xoinis, Rhiana Lau, Len Tanaka, Keith Abe, Bruce Shiramizu
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports. 5:232470961774114
Hemolytic uremic syndrome (HUS) can be classified as typical and atypical, and the treatment recommendations currently differ between the 2 types. Eculizumab is recommended as first-line treatment for atypical HUS; however, its use in typical HUS has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba9aa661719b8b33df8e3adf53c68cb6
https://doi.org/10.1177/2324709617741144
https://doi.org/10.1177/2324709617741144